Ticker
Reporting Basis
Period
From
To
Form Type
Report Format
Update Type


MIMEDX GRP INC   FYE=12 (December)

Annual - Income Statement - Company Specific

Fiscal period2021202020192018201720162015201420132012
Period End Date12/31/202112/31/202012/31/201912/31/201812/31/201712/31/201612/31/201512/31/201412/31/201312/31/2012
Net Sales258.62248.23299.26359.11321.14221.71187.30118.2259.1827.05
Grant revenue--------------------
Total Revenues258.62248.23299.26359.11321.14221.71187.30118.2259.1827.05
Cost of sales43.2839.3343.0836.3935.2230.9420.2012.679.335.19
Gross Margin215.33208.90256.17322.73285.92190.77167.09105.5649.8521.87
Amortization of intangible assets0.821.071.041.031.682.140.930.931.051.38
Research and development expenses17.3411.7211.1415.7717.9014.348.417.054.842.89
Acquired in-process research and development--------------------
Selling, general and administrative expenses198.36181.02198.21258.53220.12173.41133.3890.4846.2319.59
Impairment of intangible assets(0.05)(1.03)(0.45)--0.00------(0.37)(1.80)
Gain on sale of assets--------------------
Fair value adjustment of earn-out liability------------------(1.57)
Investigation, restatement and related(3.79)(59.47)(66.50)(51.32)------------
Operating Income (Loss)(5.04)(45.40)(21.16)(3.92)46.220.8824.367.10(2.64)(5.36)
Interest expense, net4.987.944.71------0.090.05--0.59
Change in fair value of investment, related party--------------------
Interest (expense) income, net------0.53(0.09)------(0.05)--
Other income (expense), net(0.02)0.000.28----(0.34)--------
Amortization of debt discount----------------(1.33)(1.71)
Gain on divestiture--------(1.05)----------
Financing expense associated with warrants issued in connection with convertible promissory note--------------------
Financing expense associated with issuance of common stock for registration rights waivers--------------------
Loss on extinguishment of debt--(8.20)----------------
Income (loss) before income tax provision(10.04)(61.54)(25.59)(3.40)45.090.5524.287.05(4.01)(7.66)
Income tax (benefit) provision0.25(12.26)(0.01)26.58(19.64)0.16(5.17)0.830.10--
Net Loss(10.29)(49.28)(25.58)(29.98)64.73------(4.11)--
Accretion of redeemable common stock and common stock with registration rights to fair value6.1434.04----------------
Net Income (Loss) Available to Common Shareholders(16.42)(83.33)(25.58)(29.98)64.730.3929.456.22(4.11)(7.66)
Net Earnings Per Share (Basic)(0.15)(0.77)(0.24)(0.28)0.610.000.280.06(0.04)(0.09)
Net Earnings Per Share (Diluted)(0.15)(0.77)(0.24)(0.28)0.560.000.260.05(0.04)(0.09)
Weighted Average Shares Outstanding (Basic)110.35108.26106.95105.60106.12105.93105.93105.7996.2981.65
Weighted Average Shares Outstanding (Diluted)110.35108.26106.95105.60116.11112.65113.63113.3096.2981.65